Movement Alert｜Hinge Health Rises 5.53% in Regular Trading, Raised Full-Year Revenue Guidance and New Product Expansion Continue to Drive Momentum

Market Focus00:16

On June 29, Hinge Health rose 5.53% in regular trading, trading at $83.335/share with turnover of $130 million, extending its strong performance throughout June.

On the news front, the company recently raised its full-year revenue guidance at the Movement 2026 investor conference to $818 million to $824 million, with the midpoint lifted by $20 million from prior guidance, significantly exceeding the FactSet consensus estimate of $801.6 million. The company also increased its Q2 revenue outlook to $200 million to $202 million versus analyst expectations of $193.8 million. Additionally, Hinge Health announced the integration of orthopedic surgery into its HingeSelect platform, creating a comprehensive musculoskeletal care offering spanning physical therapy, specialist evaluation, imaging, pre-habilitation, surgery, and post-operative recovery.

RBC Capital Markets raised its price target on the stock to $75 from $65, maintaining an Outperform rating, citing the company's long runway for growth driven by new products, expanding market opportunities, and a target operating model calling for 20%-25% revenue growth with operating margins above 35%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154376839?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 00:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154376839","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hinge Health Rises 5.53% in Regular Trading, Raised Full-Year Revenue Guidance and New Product Expansion Continue to Drive Momentum","media":"Market Focus","content":"<p><p>On June 29, Hinge Health rose 5.53% in regular trading, trading at $83.335/share with turnover of $130 million, extending its strong performance throughout June.</p><p>On the news front, the company recently raised its full-year revenue guidance at the Movement 2026 investor conference to $818 million to $824 million, with the midpoint lifted by $20 million from prior guidance, significantly exceeding the FactSet consensus estimate of $801.6 million. The company also increased its Q2 revenue outlook to $200 million to $202 million versus analyst expectations of $193.8 million. Additionally, Hinge Health announced the integration of orthopedic surgery into its HingeSelect platform, creating a comprehensive musculoskeletal care offering spanning physical therapy, specialist evaluation, imaging, pre-habilitation, surgery, and post-operative recovery.</p><p>RBC Capital Markets raised its price target on the stock to $75 from $65, maintaining an Outperform rating, citing the company's long runway for growth driven by new products, expanding market opportunities, and a target operating model calling for 20%-25% revenue growth with operating margins above 35%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hinge Health Rises 5.53% in Regular Trading, Raised Full-Year Revenue Guidance and New Product Expansion Continue to Drive Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hinge Health Rises 5.53% in Regular Trading, Raised Full-Year Revenue Guidance and New Product Expansion Continue to Drive Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-30 00:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 29, Hinge Health rose 5.53% in regular trading, trading at $83.335/share with turnover of $130 million, extending its strong performance throughout June.</p><p>On the news front, the company recently raised its full-year revenue guidance at the Movement 2026 investor conference to $818 million to $824 million, with the midpoint lifted by $20 million from prior guidance, significantly exceeding the FactSet consensus estimate of $801.6 million. The company also increased its Q2 revenue outlook to $200 million to $202 million versus analyst expectations of $193.8 million. Additionally, Hinge Health announced the integration of orthopedic surgery into its HingeSelect platform, creating a comprehensive musculoskeletal care offering spanning physical therapy, specialist evaluation, imaging, pre-habilitation, surgery, and post-operative recovery.</p><p>RBC Capital Markets raised its price target on the stock to $75 from $65, maintaining an Outperform rating, citing the company's long runway for growth driven by new products, expanding market opportunities, and a target operating model calling for 20%-25% revenue growth with operating margins above 35%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HNGE","symbol_name":"Hinge Health, Inc.","start_time":0,"source_url":"","article_id":"1154376839","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154376839","pubTimestamp":1782749783,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 29, Hinge Health rose 5.53% in regular trading, trading at $83.335/share with turnover of $130 million, extending its strong performance throughout June.On the news front, the company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HNGE":"Hinge Health, Inc."},"translate_title":"动感快讯|Hinge Health常规交易涨5.53%上调全年营收指引新产品拓展继续推动动能","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HNGE":1},"content_text":"On June 29, Hinge Health rose 5.53% in regular trading, trading at $83.335/share with turnover of $130 million, extending its strong performance throughout June.On the news front, the company recently raised its full-year revenue guidance at the Movement 2026 investor conference to $818 million to $824 million, with the midpoint lifted by $20 million from prior guidance, significantly exceeding the FactSet consensus estimate of $801.6 million. The company also increased its Q2 revenue outlook to $200 million to $202 million versus analyst expectations of $193.8 million. Additionally, Hinge Health announced the integration of orthopedic surgery into its HingeSelect platform, creating a comprehensive musculoskeletal care offering spanning physical therapy, specialist evaluation, imaging, pre-habilitation, surgery, and post-operative recovery.RBC Capital Markets raised its price target on the stock to $75 from $65, maintaining an Outperform rating, citing the company's long runway for growth driven by new products, expanding market opportunities, and a target operating model calling for 20%-25% revenue growth with operating margins above 35%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154376839","isCrawlerRequest":true}